2010•Journal of University of South ChinaRequires access

Effects of Atorvastatin on Non-alcoholic Steatohepatitis and Tumor Necrosis Factor-alpha in Serum of Hyperccholesterolemia Rabbits

Bing Wei

Open publisher page 0 citations

Abstract

Objective To investigate the effects of atorvastatin on the formation of non-alcoholic steatohepatitis and serum TNF-α concentration of hypercholesterolemia rabbits. Methods Twenty-four New Zealand white rabbits were randomly assigned to normal group(normal diet for 12 weeks),high cholesterol group(high-cholesterol diet for 12 weeks) and atorvastatin group(after high cholesterol diet for 8 weeks,the same cholesterol diet supplemented with atorvastatin 2.5 mg/kg/d for 4 weeks).The serum lipid and TNF-α level of rabbits were measured.Pathomorphology in hepatic tissue were detected. Result Rabbits of high cholesterol group showed higher serum levels of total cholesterol,low density lipoprotein cholesterol and TNF-α than those of control group(P0.01),and they also showed significantly more aggravated liver steatosis(R= 0.72),increased liver weight s and more fat-storing cells counting than those of control group(P0.01).Compared with high cholesterol group,atorvastatin treatment could significantly reduce the levels of serum total cholesterol,low density lipoprotein cholesterol and TNF-α(P 0.05),and significantly improve liver steatosis(R= 0.53),decrease liver weight s and fat-storing cells counting(P0.05). Conclusion Our study indicated that atorvastatin therapy could reduce the degree of liver steatosis,which might be partially dependent on its lipid-lowering effect and decreasing serum TNF-α levels in hypercholesterolemia rabbits.

About this research paper

What this paper is about

Objective To investigate the effects of atorvastatin on the formation of non-alcoholic steatohepatitis and serum TNF-α concentration of hypercholesterolemia rabbits. Methods Twenty-four New Zealand white rabbits were randomly assigned to normal group(normal diet for 12 weeks),high cholesterol group(high-cholesterol diet for 12 weeks) and atorvastatin group(after high cholesterol diet for 8 weeks,the same cholesterol diet supplemented with atorvastatin 2.5 mg/kg/d for 4 weeks).The serum lipid and TNF-α level of rabbits were measured.Pathomorphology in hepatic tissue were detected. Result Rabbits of high cholesterol group showed higher serum levels of total cholesterol,low density lipoprotein cholesterol and TNF-α than those of control group(P0.01),and they also showed significantly more aggravated liver steatosis(R= 0.72),increased liver weight s and more fat-storing cells counting than those of control group(P0.01).Compared with high cholesterol group,atorvastatin treatment could significantly reduce the levels of serum total cholesterol,low density lipoprotein cholesterol and TNF-α(P 0.05),and significantly improve liver steatosis(R= 0.53),decrease liver weight s and fat-storing cells counting(P0.05). Conclusion Our study indicated that atorvastatin therapy could reduce the degree of liver steatosis,which might be partially dependent on its lipid-lowering effect and decreasing serum TNF-α levels in hypercholesterolemia rabbits.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effects of atorvastatin on the formation of non-alcoholic steatohepatitis and serum TNF-α concentration of hypercholesterolemia rabbits. Methods Twenty-four New Zealand white rabbits were randomly assigned to normal group(normal diet for 12 weeks),high cholesterol group(high-cholesterol diet for 12 weeks) and atorvastatin group(after high cholesterol diet for 8 weeks,the same cholesterol diet supplemented with atorvastatin 2.5 mg/kg/d for 4 weeks).The serum lipid and TNF-α level of rabbits were measured.Pathomorphology in hepatic tissue were detected. Result Rabbits of high cholesterol group showed higher serum levels of total cholesterol,low density lipoprotein cholesterol and TNF-α than those of control group(P0.01),and they also showed significantly more aggravated liver steatosis(R= 0.72),increased liver weight s and more fat-storing cells counting than those of control group(P0.01).Compared with high cholesterol group,atorvastatin treatment could significantly reduce the levels of serum total cholesterol,low density lipoprotein cholesterol and TNF-α(P 0.05),and significantly improve liver steatosis(R= 0.53),decrease liver weight s and fat-storing cells counting(P0.05). Conclusion Our study indicated that atorvastatin therapy could reduce the degree of liver steatosis,which might be partially dependent on its lipid-lowering effect and decreasing serum TNF-α levels in hypercholesterolemia rabbits.

Key concepts: Atorvastatin, Steatohepatitis, Steatosis, Internal medicine, Cholesterol, Endocrinology, Medicine, Tumor necrosis factor alpha

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Atorvastatin on Non-alcoholic Steatohepatitis and Tumor Necrosis Factor-alpha in Serum of Hyperccholesterolemia Rabbits — Research Paper | ScholarLens